AstraZeneca PLC (LON:AZN)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
13,802
-232 (-1.65%)
Nov 17, 2026, 4:37 PM GMT

AstraZeneca Revenue

AstraZeneca had revenue of $16.21B USD in the quarter ending September 30, 2026, with 6.70% growth. This brings the company's total for the last twelve months to $62.38B, up 7.32% year-over-year. In the year 2025, AstraZeneca had annual revenue of $58.74B with 8.63% growth. That makes AstraZeneca the 199th largest company in the world by revenue and 6th in the United Kingdom.

Revenue (ttm)
$62.38B
Revenue Growth
+7.32%
P/S Ratio
4.56
Revenue / Employee
$649.16K
Employees
96,100
Market Cap
214.08B GBP

Revenue Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart
  • Oncology 25.62B 43.6%
  • BioPharmaceuticals: Cardiovascular, Renal & Metabolism PR (CVRM) 12.77B 21.7%
  • Rare Disease 9.13B 15.5%
  • BioPharmaceuticals: Respiratory & Immunology PR (R&I) 8.87B 15.1%
  • BioPharmaceuticals Infectious Disease PR (ID) 1.27B 2.2%
  • Other Medicines 988.00M 1.7%
  • Collaboration 99.00M 0.2%

By Geography

Chart
  • The Americas 27.56B 46.9%
  • Rest of Europe 13.46B 22.9%
  • Asia, Africa & Australasia 13.37B 22.8%
  • UK 4.36B 7.4%
Fiscal year ended Dec 31, 2025 See the full AstraZeneca breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202558.74B4.67B8.63%
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 201924.38B2.29B10.38%
Dec 31, 201822.09B-375.00M-1.67%
Dec 31, 201722.47B-537.00M-2.33%
Dec 31, 201623.00B-1.71B-6.90%
Dec 31, 201524.71B-1.84B-6.93%
Dec 31, 201426.55B741.00M2.87%
Dec 31, 201325.81B-2.17B-7.75%
Dec 31, 201227.97B-5.62B-16.72%
Dec 31, 201133.59B322.00M0.97%
Dec 31, 201033.27B465.00M1.42%
Dec 31, 200932.80B1.20B3.81%
Dec 31, 200831.60B2.04B6.91%
Dec 31, 200729.56B3.08B11.65%
Dec 31, 200626.48B2.53B10.54%
Dec 31, 200523.95B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
GSK plc33.54B
Haleon11.15B
Smith & Nephew4.77B
Hikma Pharmaceuticals2.58B
Convatec Group1.88B
Spire Healthcare Group1.58B
CVS Group712.80M
Genus658.10M
Revenue Rankings